OBJECTIVE: We compared the effects of diet/exercise induce weight loss versus pioglitazone on lipoprotein particle characteristics in non-diabetic, insulin resistant adults to determine whether the responses and potential mechanisms for improvement are similar between these two insulin sensitizing regimens. METHODS AND RESULTS:Thirty-seven obese, insulin resistant volunteers were randomized to 19 weeks of either pioglitazone or diet/exercise treatment. Insulin sensitivity (Si) by IVGTT and lipoprotein subclass particle profiles by NMR was measured. Only diet/exercise lowered TG (-40+/-11 mg/dL), total (-29+/-4 mg/dL) and LDL cholesterol (-20+/-4 mg/dL; all p<0.01). Both diet/exercise and pioglitazone improved Si (p<0.05), decreased total LDL particles (-227+/-40 and -149+/-21 nmol/L, respectively, both p<0.001) and small LDL particles (-242+/-58 and -226+/-36, respectively, both p<0.001). Large LDL particle concentrations increased with both treatments. LDL particle subclasses changes correlated with changes in Si only in the diet/exercise group. CONCLUSION: In obese, insulin resistant non-diabetic adults, pioglitazone improved LDL particle characteristics in a manner similar to diet/exercise without changing TG, diabetic control, total or LDL cholesterol. This effect could have implications for atherosclerotic risk.
RCT Entities:
OBJECTIVE: We compared the effects of diet/exercise induce weight loss versus pioglitazone on lipoprotein particle characteristics in non-diabetic, insulin resistant adults to determine whether the responses and potential mechanisms for improvement are similar between these two insulin sensitizing regimens. METHODS AND RESULTS: Thirty-seven obese, insulin resistant volunteers were randomized to 19 weeks of either pioglitazone or diet/exercise treatment. Insulin sensitivity (Si) by IVGTT and lipoprotein subclass particle profiles by NMR was measured. Only diet/exercise lowered TG (-40+/-11 mg/dL), total (-29+/-4 mg/dL) and LDL cholesterol (-20+/-4 mg/dL; all p<0.01). Both diet/exercise and pioglitazone improved Si (p<0.05), decreased total LDL particles (-227+/-40 and -149+/-21 nmol/L, respectively, both p<0.001) and small LDL particles (-242+/-58 and -226+/-36, respectively, both p<0.001). Large LDL particle concentrations increased with both treatments. LDL particle subclasses changes correlated with changes in Si only in the diet/exercise group. CONCLUSION: In obese, insulin resistant non-diabetic adults, pioglitazone improved LDL particle characteristics in a manner similar to diet/exercise without changing TG, diabetic control, total or LDL cholesterol. This effect could have implications for atherosclerotic risk.
Authors: Russell Jago; Kimberly L Drews; James D Otvos; Gary D Foster; Marsha D Marcus; John B Buse; Michele Mietus-Snyder; Steven M Willi Journal: J Pediatr Date: 2014-02-05 Impact factor: 4.406
Authors: Wilson D Pace; Angela M Lanigan; Elizabeth W Staton; Deborah G Graham; Brian K Manning; L Miriam Dickinson; Caroline B Emsermann; Elizabeth E Stewart Journal: Ann Fam Med Date: 2013 Jul-Aug Impact factor: 5.166
Authors: David J Decewicz; David M Neatrour; Amy Burke; Mary Jane Haberkorn; Heather L Patney; Marina N Vernalis; Darrell L Ellsworth Journal: Lipids Health Dis Date: 2009-06-29 Impact factor: 3.876
Authors: Mark A Sarzynski; Jeffrey Burton; Tuomo Rankinen; Steven N Blair; Timothy S Church; Jean-Pierre Després; James M Hagberg; Rian Landers-Ramos; Arthur S Leon; Catherine R Mikus; D C Rao; Richard L Seip; James S Skinner; Cris A Slentz; Paul D Thompson; Kenneth R Wilund; William E Kraus; Claude Bouchard Journal: Atherosclerosis Date: 2015-10-17 Impact factor: 5.162
Authors: Anna Karmi; Patricia Iozzo; Antti Viljanen; Jussi Hirvonen; Barbara A Fielding; Kirsi Virtanen; Vesa Oikonen; Jukka Kemppainen; Tapio Viljanen; Letizia Guiducci; Merja Haaparanta-Solin; Kjell Någren; Olof Solin; Pirjo Nuutila Journal: Diabetes Date: 2010-06-21 Impact factor: 9.461